Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vii) All inpatient clients, age distribution by primary drug (%)

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Mean age	Age known	Age not known
Opioids	0.0	3.3	16.9	28.4	23.6	13.3	8.2	6.3	31.5	16098	37
Cocaine	0.0	2.6	15.8	24.7	21.8	16.0	10.8	8.2	32.6	2378	3
Stimulants	0.2	12.3	28.1	23.0	14.9	7.5	6.5	7.4	29.1	3608	26
Hypnotics and sedatives	0.1	3.4	10.5	14.8	13.4	9.9	12.0	35.9	39.8	1538	15
Hallucinogens	0.0	8.0	33.3	30.7	20.0	6.7	1.3	0.0	26.9	75	0
Volatile substances	4.7	43.6	16.4	17.3	10.7	4.9	1.1	1.4	23.1	365	0
Cannabis	0.8	17.4	30.8	21.8	12.2	7.7	4.5	4.9	27.3	4701	13
Other substances	0.2	6.7	26.4	24.1	13.6	9.1	7.0	12.9	31.6	1543	0
Total	0.2	7.1	20.5	25.4	19.5	11.5	7.7	8.1	31.0	30306	94

Notes:

 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.   

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)